Repare Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Repare Therapeutics

13/08/2021 08:39

* Repare Therapeutics Inc  RPTX.OQ  reported a quarterly
adjusted loss of 71 cents​​ per share for the quarter ended in
June. The mean expectation of six analysts for the quarter was
for a loss of 60 cents per share.
* Revenue was $279.00 thousand​;  analysts expected $600.00
thousand. 
* Repare Therapeutics Inc's reported EPS for the quarter was a
loss of 71 cents​.
* The mean earnings estimate of analysts had fallen by
about 0.5% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Repare Therapeutics Inc shares had risen by 9.3% this
quarter and lost 0.7% so far this year.
* The company reported a quarterly loss of $26.31 million.
* Wall Street's median 12-month price target for Repare
Therapeutics Inc is $46.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 13 at 07:39 a.m.  ​All
figures in US dollars unless otherwise stated